EC Number   |
Application |
Reference |
|---|
    4.2.1.11 | biofuel production |
proteome analysis as well as enzyme assays performed in cell-free extracts demonstrates that glycerol is degraded via glyceraldehyde-3-phosphate, which is further metabolized through the lower part of glycolysis leading to formation of mainly ethanol and hydrogen. Fermentation of glycerol to ethanol and hydrogen by this bacterium represents a remarkable option to add value to the biodiesel industries by utilization of surplus glycerol |
748573 |
| 4.2.1.11 | drug development |
structure and molecular dynamics applied to design irreversible species-specific inhibitors, parasite-specific lysine residue closely to catalytic site identified |
679787 |
| 4.2.1.11 | drug development |
the glycolytic/gluconeogenic enzyme enolase is a candidate target for antiparasite drug design |
714875 |
| 4.2.1.11 | medicine |
alpha-enolase is a pancreatic ductal adenocarcinoma-associated antigen |
704073 |
| 4.2.1.11 | medicine |
changes in tumor ENO-1 levels are related to clinical 4-hydroxytamoxifen therapeutic outcome, downregulation of ENO-1 can be utilized as a pharmacological approach for overcoming 4-hydroxytamoxifen resistance in breast cancer therapy |
702980 |
| 4.2.1.11 | medicine |
recombinant alpha-enolase can confer effective protection against Streptococcus iniae infection in mice |
747973 |
| 4.2.1.11 | medicine |
salivary neuron specific enolase is an indicator for neuronal damage in patients with ischemic stroke and stroke-prone patients |
703262 |
| 4.2.1.11 | medicine |
the recombinant enzyme protein is a useful antigen in vaccination against adult worms |
716427 |
| 4.2.1.11 | medicine |
the tegumental membrane protein enolase is a vaccine candidate |
716426 |
| 4.2.1.11 | medicine |
the up-regulation of alpha-enolase expression can be a protective mechanism to neutralize oxidative and nitrative stress in diabetes |
703811 |
